No surgery: A 15-min cure for diabetes, obesity

Key points
- LONDON: In what could revolutionise healthcare for the rising diabetes population worldwide, scientists claimed to have developed a 15-minute non-surgical treatment that could lead to drastic weight loss and reverse the onset of the disease.
- The breakthrough treatment, considered a cheap and safe alternative to surgery, involves a device called EndoBarrier — a plastic sleeve that is inserted into the intestine of a patient to prevent food being absorbed into the body.
- The device, developed by a United States-based company, is fed through the mouth using an instrument called an endoscope while the patient is awake, the Daily Express reported.
- “Obesity surgery can be risky simply because of the patient’s weight and the fact that you are giving them a general anaesthetic.
LONDON: In what could revolutionise healthcare for the rising diabetes population worldwide, scientists claimed to have developed a 15-minute non-surgical treatment that could lead to drastic weight loss and reverse the onset of the disease.
The breakthrough treatment, considered a cheap and safe alternative to surgery, involves a device called EndoBarrier — a plastic sleeve that is inserted into the intestine of a patient to prevent food being absorbed into the body.
The device, developed by a United States-based company, is fed through the mouth using an instrument called an endoscope while the patient is awake, the Daily Express reported.
“Obesity surgery can be risky simply because of the patient’s weight and the fact that you are giving them a general anaesthetic. That’s why it’s so good to have a non-surgical approach,” said Keith Gersin, head of obesity surgery at Carolinas Medical Centre in Charlotte, North Carolina, which has been trialling the EndoBarrier sleeve for 18 months.
“It is so quick to fit that you can get lots more patients treated. The patients loved it so much they didn’t want us to remove it at the end of the trial period. We had no significant side effects and it was easily removed.”
Extensive tests of EndoBarrier have been carried out in the US and Europe and last week the new device was given a licence for use on European patients.
In a 12-week trial in the Netherlands, patients fitted with the EndoBarrier lost an average of 16kg compared with a control group of patients who dieted and lost just 5kg.
According to its developers, the treatment, which costs £2,000, is about half the cost of the cheapest obesity operation.
“The patients who used it have continued to lose weight. It gave them the incentive to diet and eat sensibly,” said Gersin.
The EndoBarrier device is fitted to the first two feet of the small intestine where most food is absorbed.
During trials the sleeve was able to reverse Type 2 diabetes within weeks by reducing patients’ blood sugar levels so they no longer needed to take drugs. Nadey Hakim, a leading UK consultant in weight loss surgery, said: “I would love to be able to cure a patient’s obesity with a 15-minute procedure. It’s a very clever idea”.
The EndoBarrier digestive tract liner won CE Mark approval in December, 2009, clearing the way for sales to begin in the European Union this year.
Times Syndication Service
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsCuring diabetes via surgery, without weight loss
Cristina Iaboni had the dubious distinction of being not quite obese enough. For all the pounds on her 5'5" frame, she did not meet the criteria for bariatric surgery to help control her type-2 diabetes. Yet six years…
31 May 2012
NewsExperimental bariatric surgery controls blood sugar in rats with diabetes
For the first time, scientists at the Toronto General Hospital Research Institute have shown that an experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes. A team led by Dr. Tony Lam…
21 May 2012
NewsSalk study may offer drug-free intervention to prevent obesity and diabetes
-It turns out that when we eat may be as important as what we eat. Scientists at the Salk Institute for Biological Studies have found that regular eating times and extending the daily fasting period may override the…






